Microsporidiosis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Ahmed Younes (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) No edit summary |
||
| Line 8: | Line 8: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Prevalence:=== | ===Prevalence:=== | ||
*The overall [[prevalence]] is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in [[Immunocompromised|immunocompromised patients]] with correlateing [[GI]] symptoms to microsporidosis). | *The overall [[prevalence]] is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in [[Immunocompromised|immunocompromised patients]] with correlateing [[GI]] symptoms to microsporidosis).<ref name="pmid7942725">{{cite journal |vauthors=Kotler DP, Orenstein JM |title=Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation |journal=Am. J. Gastroenterol. |volume=89 |issue=11 |pages=1998–2002 |year=1994 |pmid=7942725 |doi= |url=}}</ref><ref name="urlCDC - DPDx - Microsporidiosis">{{cite web |url=https://www.cdc.gov/dpdx/microsporidiosis/index.html |title=CDC - DPDx - Microsporidiosis |format= |work= |accessdate=}}</ref> | ||
*In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of microsporidosis was 39% being the most common isolated organism. | *In [[HIV]] patients with [[diarrhea]], the [[prevalence]] of microsporidosis was 39% being the most common isolated organism. | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to the microsporidosis. | *There is no racial predilection to the microsporidosis.<ref name="pmid16940873">{{cite journal| author=Didier ES, Weiss LM| title=Microsporidiosis: current status. | journal=Curr Opin Infect Dis | year= 2006 | volume= 19 | issue= 5 | pages= 485-92 | pmid=16940873 | doi=10.1097/01.qco.0000244055.46382.23 | pmc=3109650 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16940873 }} </ref> | ||
===Age=== | ===Age=== | ||
*Patients of all age groups may develop microspordosis. | *Patients of all age groups may develop microspordosis.<ref name="pmid16940873">{{cite journal| author=Didier ES, Weiss LM| title=Microsporidiosis: current status. | journal=Curr Opin Infect Dis | year= 2006 | volume= 19 | issue= 5 | pages= 485-92 | pmid=16940873 | doi=10.1097/01.qco.0000244055.46382.23 | pmc=3109650 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16940873 }} </ref> | ||
===Sex=== | ===Sex=== | ||
*Males and females are affected equally by microsporidosis. | *Males and females are affected equally by microsporidosis.<ref name="pmid16940873">{{cite journal| author=Didier ES, Weiss LM| title=Microsporidiosis: current status. | journal=Curr Opin Infect Dis | year= 2006 | volume= 19 | issue= 5 | pages= 485-92 | pmid=16940873 | doi=10.1097/01.qco.0000244055.46382.23 | pmc=3109650 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=16940873 }} </ref> | ||
===Geographic distribution=== | ===Geographic distribution=== | ||
*Microsporidiosis infections occur worldwide with no geographic prediliction. | *Microsporidiosis infections occur worldwide with no geographic prediliction.<ref name="urlCDC - DPDx - Microsporidiosis">{{cite web |url=https://www.cdc.gov/dpdx/microsporidiosis/index.html |title=CDC - DPDx - Microsporidiosis |format= |work= |accessdate=}}</ref> | ||
==References== | ==References== | ||
Revision as of 21:31, 2 July 2017
|
Microsporidiosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Microsporidiosis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Microsporidiosis epidemiology and demographics |
|
Risk calculators and risk factors for Microsporidiosis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ogheneochuko Ajari, MB.BS, MS [2];Associate Editor(s)-in-Chief: Ahmed Younes M.B.B.CH [3]
Overview
The case-fatality rate of intestinal microsporidiosis is approximately 56% among HIV patients. The disease is present allover the world.
Epidemiology and Demographics
Prevalence:
- The overall prevalence is not accurately estimated especially in the whole population (because microsporidosis is usually investigated in immunocompromised patients with correlateing GI symptoms to microsporidosis).[1][2]
- In HIV patients with diarrhea, the prevalence of microsporidosis was 39% being the most common isolated organism.
Race
- There is no racial predilection to the microsporidosis.[3]
Age
- Patients of all age groups may develop microspordosis.[3]
Sex
- Males and females are affected equally by microsporidosis.[3]
Geographic distribution
- Microsporidiosis infections occur worldwide with no geographic prediliction.[2]
References
- ↑ Kotler DP, Orenstein JM (1994). "Prevalence of intestinal microsporidiosis in HIV-infected individuals referred for gastroenterological evaluation". Am. J. Gastroenterol. 89 (11): 1998–2002. PMID 7942725.
- ↑ 2.0 2.1 "CDC - DPDx - Microsporidiosis".
- ↑ 3.0 3.1 3.2 Didier ES, Weiss LM (2006). "Microsporidiosis: current status". Curr Opin Infect Dis. 19 (5): 485–92. doi:10.1097/01.qco.0000244055.46382.23. PMC 3109650. PMID 16940873.